Press release
Transforming the Perjeta (Pertuzumab) Market in 2025: Rising Breast Cancer Incidence Driving Growth Of The Herceptin Biosimilars Market
Perjeta (Pertuzumab) Market
The market value of perjeta (pertuzumab) has seen quick expansion in the past few years. From $935.92 million in 2024, it's expected to increase to $1,084.80 million in 2025, with a compound annual growth rate (CAGR) of 15.9%. The rise in the historic phase can be tied down to an upsurge in its application within oncology, the growing demand for ADCs, request for targeted and less harmful treatments, a boost from inorganic growth, and the need for more personalized medicine._x000D_
_x000D_
In the coming years, the perjeta (pertuzumab) market is anticipated to experience swift expansion, with its value predicted to reach $1,932.66 million in 2029, growing at a compound annual growth rate (CAGR) of 15.5%. This predicted growth during the forecast duration can be linked to factors such as the increasing cases of breast cancer, enhanced interest in ADCs for hematologic malignancies, the rising prevalence of cancer, unfulfilled medical requirements, and an uptick in pharmaceutical research & development for cancer immunotherapy. Other notable trends influencing the market in the forecast span include the introduction of biosimilars in oncology, the creation of biosimilars and generics, breakthroughs in drug formulations, further advancements in cancer immunotherapy studies, and the increased prominence of combination therapies._x000D_
_x000D_
What Factors Are Fueling Growth in the Perjeta (Pertuzumab) Market?_x000D_
The upsurge in the occurrence of breast cancer is anticipated to fuel the advancement of the Perjeta (pertuzumab) market. Breast cancer is a disease characterized by the growth of malevolent cells in the breast tissue, usually stemming from the ducts or lobules. This growing prevalence is linked to shifts in lifestyle, such as an increase in obesity and sedentary habits, along with better early detection methods through comprehensive screening programs. Perjeta (pertuzumab) is employed to manage HER2-positive breast cancer by focusing on the HER2 receptor and is typically mixed with trastuzumab and chemotherapy to enhance treatment results. For example, Ray of Light Wales, a not-for-profit charity in the UK, stated in October 2023 that about 600,000 individuals in the UK are living post breast cancer diagnosis, and this figure is forecasted to soar to 1.2 million by 2030. Therefore, the escalating incidence of breast cancer is catalyzing the growth of the herceptin biosimilars market._x000D_
_x000D_
Get Your Free Sample Now - Explore Exclusive Market Insights:_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=19917&type=smp_x000D_
_x000D_
Which Leading Companies Are Shaping the Growth of the Perjeta (Pertuzumab) Market?_x000D_
Major companies operating in the perjeta (pertuzumab) market include Roche Holding AG _x000D_
_x000D_
What Are the Major Trends Shaping the Perjeta (Pertuzumab) Market?_x000D_
The Perjeta (pertuzumab) market is largely centered on the creation of technologically superior solutions like subcutaneous combination therapies, with a particular emphasis on enhancing patient results and ease of treatment. Such therapies combine two or more drugs in a single injection, delivered under the skin, to manage a specific health issue. For example, in November 2023, Chugai Pharmaceutical Co., Ltd., a Japanese pharmaceutical firm, introduced Phesgo, designed for the subcutaneous treatment of HER2-positive breast cancer and advanced or recurring HER2-positive colorectal cancer. This groundbreaking subcutaneous method merges the monoclonal antibodies pertuzumab and trastuzumab with vorhyaluronidase alfa. It can be administered in a mere 5 to 8 minutes, a notable reduction in time compared to traditional intravenous injections. Specifically aimed at patients suffering from advanced or recurrent HER2-positive colorectal cancer, Phesgo represents the first solution of its kind available for this affliction._x000D_
_x000D_
What Are the Key Segments of the Perjeta (Pertuzumab) Market?_x000D_
The perjeta (pertuzumab)market covered in this report is segmented - _x000D_
_x000D_
1) By Type: Human source; Animal source_x000D_
2) By Product: Monoclonal Antibody; Biologic Drug_x000D_
3) By Indication: Early Breast Cancer; Metastatic Breast Cancer_x000D_
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies_x000D_
_x000D_
Pre-Book Your Report Now For A Swift Delivery:_x000D_
https://www.thebusinessresearchcompany.com/report/perjeta-pertuzumab-global-market-report_x000D_
_x000D_
Which Region Dominates the Perjeta (Pertuzumab) Market?_x000D_
North America was the largest region in the perjeta (pertuzumab) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the perjeta (pertuzumab) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
What Is Covered In The Perjeta (Pertuzumab) Global Market Report?_x000D_
_x000D_
- Market Size Analysis: Analyze the perjeta (pertuzumab) Market Size by key regions, countries, product types, and applications._x000D_
- Market Segmentation Analysis: Identify various subsegments within the perjeta (pertuzumab) market for effective categorization._x000D_
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape._x000D_
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market._x000D_
- Market Contribution: Evaluate contributions of different segments to the overall perjeta (pertuzumab) market growth._x000D_
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers._x000D_
- Industry Challenges: Analyze challenges and risks affecting the perjeta (pertuzumab) market._x000D_
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market._x000D_
_x000D_
Unlock Exclusive Market Insights - Purchase Your Research Report Now!_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19917_x000D_
_x000D_
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Transforming the Perjeta (Pertuzumab) Market in 2025: Rising Breast Cancer Incidence Driving Growth Of The Herceptin Biosimilars Market here
News-ID: 3872978 • Views: …
More Releases from The Business Research Company
Electronic Load Market Insights Highlight Segment Expansion And Market Leadershi …
The electronic load market has experienced substantial growth recently, driven by advancements in technology and increasing demand across various sectors. As industries continue to innovate and expand, the market outlook remains highly promising with several factors set to influence its trajectory in the coming years. Below is a detailed exploration of the market size, key players, trends, and segment insights shaping the electronic load industry.
Projected Growth and Market Size of…
Elearning Authoring Tools Software Market Intelligence Report Covers Trends, Seg …
The elearning authoring tools software sector has witnessed rapid expansion, reflecting the growing importance of digital education solutions. As training and learning continue to evolve with technology, this market is poised to experience significant growth over the coming years. Let's explore the current market size, key players, emerging trends, and the main segments defining this dynamic industry.
Market Size and Growth Expectations in the Elearning Authoring Tools Software Market
The…
Edge Observability For Radio Access Network (RAN) Market Demonstrates Long-Term …
The edge observability for radio access network (RAN) market is gaining significant traction as mobile networks evolve and modernize. With increasing demand for reliable network performance and the adoption of advanced technologies, this market is set to experience substantial growth in the coming years. Let's explore the current market size, key factors driving expansion, major players, emerging trends, and the segmentation landscape shaping its future.
Projected Market Size and Growth Trajectory…
Edge Computing In Healthcare Market Analysis Highlights Growth To $14.44 Billion …
The healthcare industry is witnessing a transformative shift with the rise of edge computing technologies. As digital tools become more integral to medical operations, edge computing is playing an increasingly vital role in enhancing patient care and clinical efficiency. Let's explore the current market size, key drivers, leading companies, emerging trends, and market segmentation shaping the future of edge computing in healthcare.
Projected Expansion and Market Size of Edge Computing in…
More Releases for Perjeta
Perjeta (Pertuzumab) Market Report Analyzes Growth Factors, Challenges, and Mark …
The Perjeta (Pertuzumab) market has experienced notable expansion recently, driven by advancements in cancer treatment and diagnostic technologies. With ongoing innovations and growing patient identification efforts, this sector is positioned for continued significant growth over the coming years. Let's explore the current market size, key drivers, major industry players, emerging trends, and important market segments shaping its future.
Projected Size and Growth Trajectory of the Perjeta (Pertuzumab) Market
The market…
In-Depth Examination of Segments, Industry Trends, and Key Competitors in the Pe …
Exploring the Future of the Perjeta (Pertuzumab) Market
The Perjeta (Pertuzumab) market is poised for significant expansion in the coming years. Projections estimate that by 2030, the market size will reach $2.23 million, growing at a strong compound annual growth rate (CAGR) of 15.4%. This rapid growth is fueled by several factors including increased identification of HER2-positive patients, the broadening use of Perjeta in adjuvant therapy settings, wider adoption of…
Perjeta Market Projected to Reach USD 7.13 Billion by 2034, Growing at a CAGR of …
Polaris Market Research announces the release of its latest research report titled, "Perjeta Market Size, Share, & Industry Analysis Report: By Type, By Product (Monoclonal Antibody and Generic Drug), By Indication, By Distribution Channel, and By Region - Market Forecast, 2025-2034."
The report analyzes the Perjeta market to register a CAGR of 5.3% from 2025 to 2034. The market was valued at USD 4.24 billion in 2024 and is projected…
Perjeta (Pertuzumab) Market Forecast 2025-2034: Analysing Major Trends, Opportun …
Get 15% off on all our 2025 Global Market Reports with code FY25SAVE - Offer valid till March 31st! …
Obsessive Compulsive Disorder (OCD) Market 2020-2025: Assessment and Growth Oppo …
All information provided in the report is derived from trusted industrial sources. Global Obsessive Compulsive Disorder (OCD) Market research reports finds market figures between 2020 and 2025. The market will exhibit remarkable CAGRs in the aforementioned period.
Global Obsessive Compulsive Disorder (OCD) Market Overview:
This report studies the Global Obsessive Compulsive Disorder (OCD) Market over the forecast period of 2020 to 2025. The Global Obsessive Compulsive Disorder (OCD) Market is expected to…
Exclusive Statistical Report on Immunomodulators Market: Industry to Observe Str …
Overview of Global Immunomodulators Market:
This report provides in-depth study of “Global Immunomodulators Market 2020” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Immunomodulators Market report also provides an in-depth survey of key players in the market organization.
Some of the major key factors driving the growth of the Global Immunomodulators Market are rapid growth in prevalence of autoimmune diseases, increasing cases of organ transplantation, growing prevalence…
